Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (281)
  2. Journal Article (125)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (433)
  2. Center for Hematologic Malignancies (433)
  3. Department of Medicine (433)
  4. Hematologic Malignancies, Division of (433)
  5. Survivorship Research (433)
  6. Myeloma (246)

More Groups

People
  1. Sergio Giralt (260)
  2. Hani Hassoun (221)
  3. David Chung (206)
  4. Alexander Lesokhin (184)
  5. Gunjan Shah (161)
  6. Sham Mailankody (144)

More People

Years
  1. 2025 (11)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (154)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (29)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (433)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or Dara-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis
    Meeting Abstract

    Hagen, P.; Sidana, S.; Parker, T. L.; Walker, B. A.; Sanchorawala, V.; Zonder, J. A.; Kourelis, T.; D'Souza, A.; Landau, H. J.; Rosenthal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • AL amyloidosis: Understanding the clinical prodrome and delays in diagnosis
    Meeting Abstract

    Abdallah, N.; Hydren, J. R.; Barnes, M. S.; Wood, A.; Tuchman, S. A.; Zonder, J. A.; Bianchi, G.; Landau, H. J.; Baljevic, M.; Hoffman, J. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis
    Meeting Abstract

    Muchtar, E.; Dispenzieri, A.; Sanchorawala, V.; Hassan, H.; Mwangi, R.; Maurer, M. J.; Buadi, F.; Lee, H. C.; Qazilbash, M. H.; Kin, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A medical chart review of healthcare costs in patients with systemic amyloid light chain amyloidosis by Mayo 2012 stage in the United States
    Meeting Abstract

    Gertz, M. M. A.; Landau, H. J.; Sanchorawala, V.; Bhutani, M.; Zonder, J. A.; Rosenzweig, M.; Magee, G.; Campos, C.; Yermilov, I.; Chang, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Isatuximab in relapsed AL amyloidosis: Results of a prospective phase II trial (SWOG S1702)
    Meeting Abstract

    Parker, T. L.; Rosenthal, A.; Sanchorawala, V.; Landau, H.; Campagnaro, E. L.; Kapoor, P.; Neparidze, N.; Girnius, S.; Hagen, P.; Scott, E. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; Garcés, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save